Newsroom

National Institutes of Health (NIH) shares insights on the origin of Verantos’ AI-based deep phenotyping

Features

NIH’s National Center for Advancing Translational Sciences profiled Verantos in an article about our development, with NIH’s support, of deep phenotyping. This artificial intelligence-based capability enables the accurate identification of patients with highly specific phenotypes including disease subtypes.

Read at the original outlet
All news
Get started

Ready to advance your evidence program?

Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.